WallStreetZenWallStreetZen

NASDAQ: EWTX
Edgewise Therapeutics Inc Earnings & Revenue

EWTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$100.2M
Current Profit Margin
0%

EWTX Return on Equity

Current Company
-32.1%
Current Industry
-63.4%
Current Market
188%
EWTX's Return on Equity (-32.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when EWTX announces earnings.

EWTX Return on Assets

Current Company
-30.2%
Current Industry
3.2%
EWTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

EWTX Return on Capital Employed

Current Company
-30.98%
Current Industry
19.9%
EWTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EWTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EWTX$0.00-$98.43M-$100.16MN/AN/A
INBX$1.80M-$206.56M-$241.36M-26.85%N/A
PTGX$60.00M-$75.64M-$78.96M+14.17%N/A
AUTL$1.70M-$152.71M-$208.38M+2.90%N/A
RCUS$117.00M-$285.00M-$307.00M+69.54%N/A

EWTX earnings dates

Next earnings date
May 9, 2024

Edgewise Therapeutics Earnings & Revenue FAQ

What were EWTX's earnings last quarter?

On Invalid Date, Edgewise Therapeutics (NASDAQ: EWTX) reported Q4 2023 earnings per share (EPS) of -$0.47, up 56.67% year over year. Total Edgewise Therapeutics earnings for the quarter were -$30.14 million. In the same quarter last year, Edgewise Therapeutics's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy Edgewise Therapeutics stock.

What was EWTX's earnings growth in the past year?

As of Q1 2024, Edgewise Therapeutics's earnings has grown year over year. Edgewise Therapeutics's earnings in the past year totalled -$100.16 million.

What is EWTX's earnings date?

Edgewise Therapeutics's earnings date is Invalid Date. Add EWTX to your watchlist to be reminded of EWTX's next earnings announcement.

What was EWTX's revenue last quarter?

On Invalid Date, Edgewise Therapeutics (NASDAQ: EWTX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Edgewise Therapeutics's revenue was $0.00.

What was EWTX's revenue growth in the past year?

As of Q1 2024, Edgewise Therapeutics's revenue has grown null year over year. Edgewise Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.